- Email: [email protected]
Wangen takes over Knoll's progressing cavity pumps division
NEWS
Wangen takes over Knoll’s progressing cavity pumps division
P
umpenfabrik Wangen GmbH is acquiring Knoll Maschinenbau GmbH’s hygienic progressing cavity pumps (MX range) division with effect from 1 April 2019. In recent years, Wangen has expanded its hygienic pump range with the Hyline progressing cavity and Twin NG twin screw pumps. Now, Wangen will add Knoll’s MX range of pumps to this business area. With their modular design and robust construction, MX progressing cavity pumps are ideal for use in the hygienic field, as well as in the chemical, paint, lacquer and paper industries. A key feature of the MX range is its EvenWall technology version, which offers significantly higher pressure stability. The pumps also have high hygiene standards around the joints and seals. “We are adding the leading hygienic progressing cavity pump to our strong hygienic twin screw pump range, offering customers in future a considerably wider range from a single supplier,” said Markus Hofheinz, managing director of Pumpenfabrik Wangen GmbH. The MX range will be handled through the Wangen sales network and existing Knoll sales partners. The acquisition is an important milestone in Wangen’s long-term growth strategy, developed and implemented together with its majority shareholder Silverfleet Capital (see Pump Industry Analyst, September 2017). “Knoll’s progressing cavity pumps complement Wangen’s portfolio of pumps excellently, particularly in the field of hygienic and industrial applications and will not only help us to further penetrate our key markets, but will also support our continued international growth,” added Hofheinz. Knoll is planning to focus on its core business – products for chip and lubricant management in metalworking. “For our progressing cavity pumps unit we were looking for a buyer who wants to further develop the business and will continue to deliver high standards in quality and service for our long-standing client base. With Pumpenfabrik Wangen we have found the ideal partner,” said Matthias Knoll, managing partner at Knoll Maschinenbau GmbH. 14
Pump Industry Analyst
For further information, visit www.wangen.com, www.knoll-mb.de and www.silverfleetcapital.com
ITT to buy Rheinhütte Pumpen Group
I
TT Inc has signed an agreement to acquire the Rheinhütte Pumpen Group from Belgium’s Aliaxis Group SA for approximately US$91.5 million. Headquartered in Wiesbaden, Germany, Rheinhütte designs and manufactures centrifugal and axial flow pumps for chemical, mining, renewable energy and refinery applications. Rheinhütte employs 430 people and is expecting full-year 2018 revenues of around US$66 million. ITT says that the acquisition of Rheinhütte will enhance its Industrial Process (IP) segment’s strategy with a complementary portfolio of centrifugal pump technologies suited to corrosive, abrasive and high-temperature industrial process environments. The US company also says that the acquisition will bolster IP’s presence in Europe with an expanded product range as well as enhanced pump engineering, manufacturing, testing and channel to market capabilities. “The proposed agreement will bring together two companies with long legacies of application expertise across a range of harsh conditions in the industrial process space,” said ITT CEO and president Luca Savi. “We look forward to leveraging Rheinhütte’s deep engineering capabilities to deliver better solutions for our customers and unlock additional growth in key global markets.” “The addition of the Rheinhütte Pumpen brand to our current portfolio will broaden our worldwide pump presence,” said ITT IP president David Malinas. “We are excited to join these two teams, leveraging their shared skills and commitment to delivering excellent products for our customers and partners.” The cash consideration of approximately US$91.5 million will be funded from the company’s cash and revolving credit facility and the final purchase price is subject to customary net working capital adjustments. The proposed transaction is expected to close in the second quarter of 2019 and is subject to customary closing conditions, including appropriate regulatory approvals. For further information, visit www.itt.com, www.rheinhuette.de/en/ and www.aliaxis.com/home/
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Subscription Information An annual subscription to Pump Industry Analyst includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received. More information:
www.elsevier.com/journals/institutional/pump-industryanalyst/1359-6128 Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘Gen eral Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid ad vances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 12979 The content of this newsletter is compiled from a variety of sources including press releases.
February 2019
Wangen takes over Knoll’s progressing cavity pumps division
P
umpenfabrik Wangen GmbH is acquiring Knoll Maschinenbau GmbH’s hygienic progressing cavity pumps (MX range) division with effect from 1 April 2019. In recent years, Wangen has expanded its hygienic pump range with the Hyline progressing cavity and Twin NG twin screw pumps. Now, Wangen will add Knoll’s MX range of pumps to this business area. With their modular design and robust construction, MX progressing cavity pumps are ideal for use in the hygienic field, as well as in the chemical, paint, lacquer and paper industries. A key feature of the MX range is its EvenWall technology version, which offers significantly higher pressure stability. The pumps also have high hygiene standards around the joints and seals. “We are adding the leading hygienic progressing cavity pump to our strong hygienic twin screw pump range, offering customers in future a considerably wider range from a single supplier,” said Markus Hofheinz, managing director of Pumpenfabrik Wangen GmbH. The MX range will be handled through the Wangen sales network and existing Knoll sales partners. The acquisition is an important milestone in Wangen’s long-term growth strategy, developed and implemented together with its majority shareholder Silverfleet Capital (see Pump Industry Analyst, September 2017). “Knoll’s progressing cavity pumps complement Wangen’s portfolio of pumps excellently, particularly in the field of hygienic and industrial applications and will not only help us to further penetrate our key markets, but will also support our continued international growth,” added Hofheinz. Knoll is planning to focus on its core business – products for chip and lubricant management in metalworking. “For our progressing cavity pumps unit we were looking for a buyer who wants to further develop the business and will continue to deliver high standards in quality and service for our long-standing client base. With Pumpenfabrik Wangen we have found the ideal partner,” said Matthias Knoll, managing partner at Knoll Maschinenbau GmbH. 14
Pump Industry Analyst
For further information, visit www.wangen.com, www.knoll-mb.de and www.silverfleetcapital.com
ITT to buy Rheinhütte Pumpen Group
I
TT Inc has signed an agreement to acquire the Rheinhütte Pumpen Group from Belgium’s Aliaxis Group SA for approximately US$91.5 million. Headquartered in Wiesbaden, Germany, Rheinhütte designs and manufactures centrifugal and axial flow pumps for chemical, mining, renewable energy and refinery applications. Rheinhütte employs 430 people and is expecting full-year 2018 revenues of around US$66 million. ITT says that the acquisition of Rheinhütte will enhance its Industrial Process (IP) segment’s strategy with a complementary portfolio of centrifugal pump technologies suited to corrosive, abrasive and high-temperature industrial process environments. The US company also says that the acquisition will bolster IP’s presence in Europe with an expanded product range as well as enhanced pump engineering, manufacturing, testing and channel to market capabilities. “The proposed agreement will bring together two companies with long legacies of application expertise across a range of harsh conditions in the industrial process space,” said ITT CEO and president Luca Savi. “We look forward to leveraging Rheinhütte’s deep engineering capabilities to deliver better solutions for our customers and unlock additional growth in key global markets.” “The addition of the Rheinhütte Pumpen brand to our current portfolio will broaden our worldwide pump presence,” said ITT IP president David Malinas. “We are excited to join these two teams, leveraging their shared skills and commitment to delivering excellent products for our customers and partners.” The cash consideration of approximately US$91.5 million will be funded from the company’s cash and revolving credit facility and the final purchase price is subject to customary net working capital adjustments. The proposed transaction is expected to close in the second quarter of 2019 and is subject to customary closing conditions, including appropriate regulatory approvals. For further information, visit www.itt.com, www.rheinhuette.de/en/ and www.aliaxis.com/home/
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Subscription Information An annual subscription to Pump Industry Analyst includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received. More information:
www.elsevier.com/journals/institutional/pump-industryanalyst/1359-6128 Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘Gen eral Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid ad vances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 12979 The content of this newsletter is compiled from a variety of sources including press releases.
February 2019